Literature DB >> 8676124

Revision total hip arthroplasty with shelf bulk allografts. A long-term follow-up study.

E Morsi1, D Garbuz, A E Gross.   

Abstract

A series of 29 shelf ( < 50% of the acetabulum) structural allografts were done in conjunction with acetabular revision with a minimum follow-up period of 5 years (average, 7.1 years). At the latest follow-up examination, 86% of the hips were successful both clinically and radiologically. Only four patients required further surgery, with two of these being revised with no additional grafts. The use of bulk allograft in conjunction with acetabular revision is supported, provided that at least 50% support of the cup can be obtained with host-bone. This type of reconstruction provides support for the cup and restores anatomy, leg length, and bone stock should future revision be necessary.

Entities:  

Mesh:

Year:  1996        PMID: 8676124     DOI: 10.1016/s0883-5403(96)80165-3

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  4 in total

1.  [Biological acetabular defect reconstruction in revision hip arthroplasty using impaction bone grafting and an acetabular reconstruction ring].

Authors:  M J Friedrich; S Gravius; J Schmolders; M D Wimmer; D C Wirtz
Journal:  Oper Orthop Traumatol       Date:  2014-04-03       Impact factor: 1.154

Review 2.  [Arthroplasty for osteoarthritis secondary to hip dysplasia: Problem-oriented treatment strategies].

Authors:  K P Günther; M Stiehler; J Goronzy; W Schneiders; A Hartmann
Journal:  Orthopade       Date:  2015-07       Impact factor: 1.087

3.  Tantalum augments for Paprosky IIIA defects remain stable at midterm followup.

Authors:  Daniel J Del Gaizo; Vamsi Kancherla; Scott M Sporer; Wayne G Paprosky
Journal:  Clin Orthop Relat Res       Date:  2012-02       Impact factor: 4.176

4.  Excellent long-term results of the Müller acetabular reinforcement ring in primary cup revision.

Authors:  Pascal Mueller Greber; Isabella Manzoni; Peter E Ochsner; Thomas Ilchmann; Lukas Zwicky; Martin Clauss
Journal:  Acta Orthop       Date:  2017-08-03       Impact factor: 3.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.